Smartleaf Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-395
Closed -$40.3K 3559
2025
Q4
$40.3K Buy
395
+43
+12% +$3.45K ﹤0.01% 1658
2025
Q3
$18.8K Buy
352
+256
+267% +$12.8K ﹤0.01% 1836
2025
Q2
$5.15K Sell
96
-215
-69% -$10.9K ﹤0.01% 2040
2025
Q1
$13.6K Sell
311
-79
-20% -$4K ﹤0.01% 1795
2024
Q4
$21.9K Buy
390
+68
+21% +$4.23K ﹤0.01% 1597
2024
Q3
$21.2K Buy
322
+245
+318% +$13.8K ﹤0.01% 1309
2024
Q2
$3.42K Buy
+77
New +$4.24K ﹤0.01% 1987

Other funds holding EXAS

Smartleaf Asset Management's EXAS Position: Q1 2026 in Review

Smartleaf Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 395 shares — an estimated $40.3K sold.

Smartleaf Asset Management first reported a position in EXAS in Q2 2024 and held it in 7 quarters. The position peaked at $40.3K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Smartleaf Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Smartleaf Asset Management sold 395 Exact Sciences shares in Q1 2026, an estimated $40.3K.
  • Smartleaf Asset Management first reported a position in Exact Sciences in Q2 2024 and held it in 7 quarters.
  • Smartleaf Asset Management's Exact Sciences position peaked at $40.3K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.